Health-care companies fell amid concerns about regulation from the Trump administration. A retreat for UnitedHealth Group continued after President-elect Donald Trump vowed to root "middle men" out of ...
Investors' focus could, however, shift back onto the possible market impacts of GLP-1 agonists in 2025, particularly as a result of a major expansion of current supplies after Novo Nordisk was given a ...
The president-elect is set to appear with SoftBank Group CEO Masayoshi Son at Mar-a-Lago on Monday. The industrial conglomerate said its board continued to explore strategic alternatives and plans to ...
Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a ...